Revision Lumbar Fusion Patients Exhibit Higher Long-Term Opioid and Gabapentinoid Needs Despite Similar Early Postoperative Use
Revision lumbar fusion patients demonstrate a greater pre- and postoperative opioid burden, and a greater postoperative gabapentinoid burden. Multivariable analysis confirms revision status as an independent risk factor of greater long-term MME use, beginning at 1 year. Together these findings suggest a complex, possibly neuropathic pain phenotype in revision patients, underscoring the need for tailored perioperative counseling and consistent long-term, multidisciplinary pain management.
Authors
- Nicholas B. Pohl (ORCID: https://orcid.org/0000-0002-9438-904X)
- Gregorio Baek
- Chloe Herczeg
- Matthew Sherman (ORCID: https://orcid.org/0000-0002-3258-3568)
- Rachel Huang (ORCID: https://orcid.org/0000-0002-7683-8702)
- Anastasia Kaffenes
- Jarod Olson (ORCID: https://orcid.org/0000-0002-3523-1680)
- Joshua Mathew (ORCID: https://orcid.org/0000-0001-5743-2670)
- Robert J. Oris (ORCID: https://orcid.org/0000-0001-8743-0860)
- Marco Goldberg
- Yasmine Eichbaum
- Joydeep Baidya
- Alan S. Hilibrand
- Jonathan Dalton
- Gregory D. Schroeder
- Alexander R. Vaccaro
- Nick DeMario
- Morgan Hitchner
- Christopher K. Kepler
- Mitchell Ng
- Thomas Cha
- Samuel Duggan
- Yulia Lee
Institutions
- National Medical Products Administration (CN)
- Thomas Jefferson University Hospital (US)
- Foundation for Human Potential (US)
- Ta Solutions (China) (CN)
- Rothman Institute (US)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- Spine
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1097/brs.0000000000005678
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00